Back to Search

ROLAND FIGUEREDO, M.D

M.D

Internal Medicine Physician

NPI: 1093825945Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

119118(NY)

Research & Publications (11)

Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
PMID 19150418·Biochim Biophys Acta·2009
7-preclinical
ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
PMID 18358073·DNA Cell Biol·2008
8-other
Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss.
PMID 16652132·Int J Obes (Lond)·2006
8-other
The micelle-bound structure of an antimicrobial peptide derived from the alpha-chain of bovine hemoglobin isolated from the tick Boophilus microplus.
PMID 15850378·Biochemistry·2005
4-observational
Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats.
PMID 15816360·Exp Toxicol Pathol·2005
7-preclinical
Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
PMID 15135315·Int Immunopharmacol·2004
7-preclinical
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
PMID 15117987·J Clin Oncol·2004
3-trial
Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein. Molecular, functioanl, and immunoprotection analysis.
PMID 12551912·J Biol Chem·2003
7-preclinical
Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies.
PMID 12616957·Methods Find Exp Clin Pharmacol·2002
4-observational
Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.
PMID 11394532·Hybridoma·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
515 AUDUBON AVE
NEW YORK, NY 10040

Quick Facts

NPI
1093825945
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
11

Are you this provider?

Claim Your Profile